Loading insider details...
Beta
Latest Form 4 (Oct 1, 2026): Sale of 27,370 LEGN shares, $258.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Legend Biotech Corp (LEGN) | Sale | 27,370 | $258.9K |
| Sep 28, 2026 | Legend Biotech Corp (LEGN) | Grant/Award | 20,986 | n/a |
| Aug 19, 2026 | Calidi Biotherapeutics, Inc. (CLDI) | Grant/Award | 6,000 | n/a |
| Jun 15, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 2,000 | $50.1K |
| May 27, 2026 | BeOne Medicines Ltd. (ONC) | Sale | 212 | $65.6K |
| May 18, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 7,751 | n/a |
| Dec 1, 2025 | BeOne Medicines Ltd. (ONC) | Exercise/Conversion | 2,627 | $417.8K |
| Sep 9, 2025 | BeOne Medicines Ltd. (ONC) | Exercise/Conversion | 2,665 | $414.9K |
| Jun 23, 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 2,405 | $89.9K |
| May 22, 2025 | BeiGene, Ltd. (BGNE) | Grant/Award | 10,985 | n/a |